HOME

TheInfoList



OR:

ICON (Public Limited Company) is a NASDAQ listed multinational clinical research organisation that provides consulting, clinical development and commercialization services for the pharmaceutical industry. Irish-headquartered healthcare intelligence and , ICON had 38,000 employees in 147 locations spread across 46 countries.


History

ICON was founded in Dublin, Ireland, by John Climax and Ronan Lambe in 1990. Since January 2010, Climax has held a position on the board of directors. Lambe retired from the board of directors in 2018. Between 1991 and 1996, ICON opened offices in the United Kingdom, United States, and Japan. A year later, ICON shares started to be traded on Nasdaq. In 2018, ICON won the ''PharmaTimes'' Clinical Researcher of the Year. ICON received 2019 Clinical Research Organization leadership awards in five categories, determined by ''Life Science Leader'' magazine and Industry Standard Research (ISR). In March 2017, Steve Cutler was appointed Chief Executive Officer of ICON. He had previously been with Quintiles South Africa,
Sandoz Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States (global research).name="novartis.com">https://www.novartis.com/research-development/research-loca ...
AG, and Kendle Intl Inc, before joiníng ICON Clinical Research Services in 2011, and becoming Chief Operating Officer in 2014.


2021 Acquisition of PRA Health Sciences

In 2013 the company was acquired by
Kohlberg Kravis Roberts KKR & Co. Inc., also known as Kohlberg Kravis Roberts & Co., is an American global investment company that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, credit, and, through its strate ...
, which brought the company public in November 2014 and maintained shares until September 2019. In August 2017, the company acquired
Conshohocken Conshohocken ( ; Lenape: ''Kanshihàkink'') is a borough on the Schuylkill River in Montgomery County, Pennsylvania in suburban Philadelphia. Historically a large mill town and industrial and manufacturing center, after the decline of industry in ...
-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million. PRA's 2018 revenue was US$2.87 billion. PRA was acquired by ICON PLC on 1 July 2021.


Acquisitions

* 2000: ICON acquired UK-based regulatory consultancy, YRCR Ltd.; Central Laboratory in New York; and bioanalytical consultancy, Pacific Research * 2002: ICON acquired clinical research provider, BPA. * 2003: ICON acquired Medeval, a UK-based Phase I facility, and US consulting firm, Globomax * 2004: ICON acquired medical imaging specialist, Beacon Bioscience Inc. * 2006: ICON acquired outcomes research and health economics specialist, Ovation Research Group * 2007: ICON acquired European staffing group, DOCS International * 2008: ICON acquired US phase I provider, Healthcare Discoveries and US bioanalytical lab, Prevalere Life Sciences * 2009: ICON acquired Veeda Laboratories, a UK biomarker lab * 2010: ICON acquired Timaq Medical Imaging Inc. * 2011: ICON acquired Oxford Outcomes, an international health outcomes consultancy and Firecrest Clinical, a technology provider specialising in site performance and study management * 2012: ICON acquired PriceSpective, a global value strategy consultancy and Chinese CRO, BeijingWits * 2013: ICON acquired staffing and FSP providers, ClinForce and Assent and Akos, an EU provider of pharmacovigilance and drug safety services * 2014: ICON acquired Aptiv Solutions, a market leader in adaptive trial design and execution * 2015: ICON acquired MediMedia Pharma Solutions to enhance market access and scientific communications capabilities, and PMG Research Inc., an integrated network of clinical research sites in the US * 2016: ICON acquired Clinical Research Management Inc., to extend its presence in the government-sponsored research market * 2017: ICON acquired MAPI Group, thereby becoming the world’s second-largest provider of late-phase services * 2019: ICON acquired Symphony Clinical Research, a leading provider of at-home patient services and site-support services; MediNova, an integrated network of clinical research sites across EMEA; and MolecularMD, to enhance its laboratory offerings in molecular diagnostic testing and immunohistochemistry * 2021: ICON acquired
PRA Health Sciences PRA Health Sciences was a contract research organization (CRO) with headquarters in Raleigh, North Carolina. It was established in 1976 and acquired by ICON in 2021. Background PRA was founded as the Anti-Inflammatory Drug Study Group in 1976, r ...
, a competitor offering clinical research services, for USD 12 billion.Upon completion of the transaction, PRA shareholders will own approximately 34 percent of the shares of the combined company and ICON shareholders will own approximately 66 percent.


See also

*
List of companies of Ireland This is a list of notable companies based in Ireland, or subsidiaries according to their sector. It includes companies from the entire island. The state of the Republic of Ireland covers five-sixths of the island, with Northern Ireland, part of th ...


References


External links


Official website
{{Finance links , name = ICON PLC , symbol = ICLR , sec_cik = ICLR , yahoo = ICLR Companies listed on the Nasdaq Pharmaceutical companies of Ireland Irish companies established in 1990 Pharmaceutical companies established in 1990 Contract research organizations